8-K/A

AMENDMENT TO CURRENT REPORT

Company: CNS Pharmaceuticals, Inc.
Filed: September 16, 2020
Period of Report: September 16, 2020
Accession Number: 0001683168-20-003145

View Document ↗ View on SEC.gov ↗